The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Novel urine markers for diagnosing and monitoring non-indolent prostate cancer.
 
Daniella Bianchi-Frias
No Relationships to Disclose
 
Ilsa Coleman
No Relationships to Disclose
 
John Samuel Banerji
No Relationships to Disclose
 
Khanh Ngoc Pham
No Relationships to Disclose
 
Claudio Jeldres
No Relationships to Disclose
 
Roman Gulati
No Relationships to Disclose
 
Jing Xia
No Relationships to Disclose
 
Scott A. Tomlins
Honoraria - Ventana Medical Systems
Consulting or Advisory Role - Ventana Medical Systems
Research Funding - Thermo Fisher Scientific (Inst)
Patents, Royalties, Other Intellectual Property - I am a coauthor on a patent issued to the University of Michigan on ETS gene fusions in prostate cancer. The diagnostic field of use has been licensed to Hologic/Gen-Probe Inc., who has sublicensed some rights to Ventana Medical Systems/Roche.
 
Christopher R. Porter
No Relationships to Disclose
 
Peter Nelson
Honoraria - Astellas Pharma; Johnson & Johnson; Tokai Pharmaceuticals
Consulting or Advisory Role - Astellas Pharma; Johnson & Johnson; Tokai Pharmaceuticals
Travel, Accommodations, Expenses - Astellas Pharma; Johnson & Johnson